Jon Jones’ potential doping violation is no longer a “potential” one. The current UFC light heavyweight champion has received the results of a B sample collected one day before his latest fight at UFC 214 in late July, also testing positive for turinabol, an anabolic steroid. ESPN’s Brett Okamoto was the first to report on the news, later confirmed by MMA Fighting’s Marc Raimondi with UFC vice president of athlete health and performance Jeff Novitzky.
Results of the B sample are often seen as a formality, considering how rare it is for them to contradict the A sample.
The talented light heavyweight — who competed in Anaheim, Calif., after testing positive — is currently scheduled to meet with the California State Athletic Commission for a disciplinary hearing on Oct. 17 in Los Angeles. It’s expected Jones will request a postponement while he and his team prepare themselves for the adjudication process.
Jones’ manager Malki Kawa immediately suspected a tainted supplement was to blame for Jones’ failed test, while one coach at Jackson-Wink MMA, where Jones trains, suspected foul play of some sort.
This marks the second time Jones has tested positive for performance-enhancing drugs in just a little over 12 months, first being flagged by the U.S. Anti-Doping Agency for PEDs last July. The first failed test came just days before a scheduled main event against Daniel Cormier at UFC 200. He was banned from competing inside the Octagon for 12 months despite successfully arguing that the positive test stemmed from improperly labeled male-enhancement supplements.
The second violation was revealed just a few weeks after he ultimately defeated Cormier to regain the UFC light heavyweight championship. This time, Jones, 30, faces up to four years on the sidelines.
Jones is widely regarded as one of the best fighters in the history of combat sports, if not the overall best.